Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 1767131)

Published in Heart on June 01, 2002

Authors

M Licka1, R Zimmermann, J Zehelein, T J Dengler, H A Katus, W Kübler

Author Affiliations

1: Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Articles citing this

Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ (2005) 2.23

Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78

Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38

Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics (Sao Paulo) (2013) 1.14

Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med (2005) 1.10

Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart (2007) 0.98

Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI. Clin Res Cardiol (2011) 0.93

Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol (2009) 0.87

Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine. Trials (2014) 0.87

Cardiac troponin-T and CK-MB (mass) levels in cardiac and non cardiac disease. Indian J Clin Biochem (2004) 0.85

A review of troponins in ischemic heart disease and other conditions. Int J Angiol (2007) 0.84

Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction. Clin Res Cardiol (2008) 0.81

Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. Am Heart J (2008) 0.79

Cardiac Troponins in Dogs and Cats. J Vet Intern Med (2015) 0.78

Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass. J Transl Med (2014) 0.78

Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care (2013) 0.78

The Correlation between Infarct Size and the QRS Axis Change after Thrombolytic Therapy in ST Elevation Acute Myocardial Infarction. Eurasian J Med (2012) 0.77

Cardioprotection from ischemia-reperfusion injury by near-infrared light in rats. Photomed Laser Surg (2014) 0.76

Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study. J Am Heart Assoc (2015) 0.76

Profiling of cell stress protein expression in cardiac tissue of cardiosurgical patients undergoing remote ischemic preconditioning: implications for thioredoxin in cardioprotection. J Transl Med (2015) 0.76

Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery. Interact Cardiovasc Thorac Surg (2016) 0.75

Identification of High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction using Strain Doppler Echocardiography: Correlation with Cardiac Magnetic Resonance Imaging. Clin Med Insights Cardiol (2016) 0.75

Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction. Res Cardiovasc Med (2015) 0.75

Articles cited by this

Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation (1991) 2.87

Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol (1991) 1.85

The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation (1979) 1.75

Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem (1992) 1.59

Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med (1986) 1.48

Enzymatic estimation of infarct size. Thrombolysis induced its demise: will it now rekindle its renaissance? Circulation (1990) 1.44

Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41

Value and limitations of thallium-201 scintigraphy in the acute phase of myocardial infarction. N Engl J Med (1976) 1.36

Correlation of mortality rate and serum enzymes in myocardial infarction. Test of efficiency of coronary care. Br Heart J (1971) 1.33

Current concepts of "normal values," "reference values," and "discrimination values," in clinical chemistry. Clin Chem (1975) 1.32

Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol (1995) 1.21

Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers? Clin Chim Acta (1997) 1.08

Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. J Am Coll Cardiol (1998) 0.97

Influence of reperfusion on serum concentrations of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol (1987) 0.95

Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. Br Heart J (1995) 0.89

Correlation of radionuclide estimates of myocardial infarction size and release of creatine kinase-MB in man. Circulation (1980) 0.86

Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med (1980) 0.86

Plasma MB creatine kinase after vigorous exercise in professional athletes. Am J Cardiol (1984) 0.84

Early appearance of MB-creatine kinase activity in nontransmural myocardial infarction detected by a sensitive assay for the isoenzyme. Am J Med (1981) 0.84

Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes. Ann Clin Biochem (1996) 0.84

Serum creatine phosphokinase in chronic alcoholism. Acta Med Scand (1967) 0.83

Serum creatine kinase B subunit activity in diagnosis of acute myocardial infarction. Br Heart J (1980) 0.82

Three-dimensional ROI-based quantification of stress/rest 201Tl myocardial SPECT: presentation of a method. Nuklearmedizin (1986) 0.81

[Myocardial infarct: acute intervention]. Z Kardiol (1993) 0.78

Articles by these authors

Simultaneous determination of the total number of aquatic bacteria and the number thereof involved in respiration. Appl Environ Microbiol (1978) 10.53

Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05

Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94

The prognostic value of serum troponin T in unstable angina. N Engl J Med (1992) 5.04

Hsp90 chaperones protein folding in vitro. Nature (1992) 3.19

Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol (1998) 2.73

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation (2001) 2.36

Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest (1999) 2.32

Novel metal cluster in the iron-molybdenum cofactor of nitrogenase. Spectroscopic evidence. J Biol Chem (1978) 2.32

Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27

Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J (2000) 2.16

Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol (1995) 2.11

Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol (1993) 2.10

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09

The effect of aortic valve replacement on survival. Circulation (1982) 2.03

M13 procoat and a pre-immunoglobulin share processing specificity but use different membrane receptor mechanisms. Proc Natl Acad Sci U S A (1983) 1.90

Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 1.86

Energetics and intermediates of the assembly of Protein OmpA into the outer membrane of Escherichia coli. J Biol Chem (1983) 1.84

Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res (2000) 1.84

Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem (1998) 1.75

Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation (1981) 1.68

Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation (2000) 1.67

Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation (2001) 1.64

Effectiveness of end-tidal carbon dioxide tension for monitoring thrombolytic therapy in acute pulmonary embolism. Crit Care Med (2000) 1.61

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61

Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation (1995) 1.61

Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol (1997) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Hibernating myocardium: an incomplete adaptation to ischemia. Circulation (1997) 1.60

Inhibition of ventricular stimulation in patients with dual chamber pacemakers and prolonged AV conduction. Pacing Clin Electrophysiol (1999) 1.59

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58

Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem (1997) 1.58

Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol (2006) 1.58

Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol (2000) 1.58

Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X") Circulation (1989) 1.57

Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J (2000) 1.56

Cardiomyopathies: from genetics to the prospect of treatment. Lancet (2001) 1.54

Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley. Clin Res Cardiol (2007) 1.54

Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circ Res (2000) 1.54

Nitrogenase X: Mössbauer and EPR studies on reversibly oxidized MoFe protein from Azotobacter vinelandii OP. Nature of the iron centers. Biochim Biophys Acta (1978) 1.54

Mussel-mimetic tissue adhesive for fetal membrane repair: a standardized ex vivo evaluation using elastomeric membranes. Prenat Diagn (2011) 1.53

Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies. Br J Haematol (1994) 1.53

Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol (1970) 1.52

Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. Eur Heart J (2002) 1.51

Different transport pathways of individual precursor proteins in mitochondria. Eur J Biochem (1981) 1.51

Fetal ultrasound biometry: 1. Head reference values. Br J Obstet Gynaecol (1999) 1.51

The biosynthesis of membrane-bound M13 coat protein. Energetics and assembly intermediates. J Biol Chem (1982) 1.50

Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Cardiovasc Res (2000) 1.50

A unique pitfall in percutaneous coronary angioplasty of in-stent restenosis: guidewire passage out of the stent. Catheter Cardiovasc Interv (2001) 1.49

Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation (1997) 1.48

Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther (1997) 1.47

Increased activity of membrane-associated nucleoside diphosphate kinase and inhibition of cAMP synthesis in failing human myocardium. Cardiovasc Res (2001) 1.46

Nitrogenase XII. Mössbauer studies of the MoFe protein from Clostridium pasteurianum W5. Biochim Biophys Acta (1980) 1.46

Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation (2000) 1.46

Transport of proteins into mitochondria. Posttranslational transfer of ADP/ATP carrier into mitochondria in vitro. Eur J Biochem (1980) 1.45

Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning. Cardiovasc Res (2001) 1.45

ACE inhibition improves vagal reactivity in patients with heart failure. Am Heart J (1990) 1.45

Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol (1989) 1.45

Kinetic studies on the transport of cytoplasmically synthesized proteins into the mitochondria in intact cells of Neurospora crassa. Eur J Biochem (1977) 1.44

Atrial sensing and AV synchrony in single lead VDD pacemakers: a prospective comparison to DDD devices with bipolar atrial leads. J Cardiovasc Electrophysiol (1999) 1.43

Comparison of the performance of four microtube column agglutination systems in the detection of red cell alloantibodies. Transfusion (1999) 1.43

[18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)]. Infusionsther Transfusionsmed (1994) 1.42

In-utero fetal therapy with immunoglobulin for alloimmune thrombocytopenia. Lancet (1992) 1.42

S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

External beam radiation after stent implantation increases neointimal hyperplasia by augmenting smooth muscle cell proliferation and extracellular matrix accumulation. J Am Coll Cardiol (1999) 1.41

Import of frog prepropeptide GLa into microsomes requires ATP but does not involve docking protein or ribosomes. EMBO J (1987) 1.41

Refractory oedema in congestive heart failure: a contributory role of loop diuretics? J Intern Med (1995) 1.40

Import of honeybee prepromelittin into the endoplasmic reticulum: structural basis for independence of SRP and docking protein. EMBO J (1987) 1.39

Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol (1992) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function. Cardiovasc Drugs Ther (1992) 1.39

Import of honeybee prepromelittin into the endoplasmic reticulum. Requirements for membrane insertion, processing, and sequestration. J Biol Chem (1986) 1.39

Transferral of extrathoracic donor neoplasm by the cardiac allograft. J Heart Lung Transplant (1997) 1.39

Inhibition of lipid peroxidation in isolated inner membrane of rat liver mitochondria by superoxide dismutase. FEBS Lett (1973) 1.39

Homologs of the yeast Sec complex subunits Sec62p and Sec63p are abundant proteins in dog pancreas microsomes. Proc Natl Acad Sci U S A (2000) 1.39

Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study. Eur J Nucl Med (1992) 1.38

Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis (2001) 1.38

A microsomal ATP-binding protein involved in efficient protein transport into the mammalian endoplasmic reticulum. EMBO J (1996) 1.38

Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res (1984) 1.38

Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J Biol Chem (1999) 1.37

Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol (2000) 1.36

Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Cell-free synthesis of cytochrome c. FEBS Lett (1979) 1.33

Chemical synthesis and enzymic processing of precursor forms of cecropins A and B. J Biol Chem (1989) 1.32

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol (1997) 1.30

Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta (1996) 1.29

The reaction specificities of the thylakoidal processing peptidase and Escherichia coli leader peptidase are identical. EMBO J (1989) 1.28

Functions and pathologies of BiP and its interaction partners. Cell Mol Life Sci (2009) 1.28

Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis (2011) 1.28